|
"Pharmacogenomics: Changing the Future of
Medicine"
William Beck, PhD, Dept. of
Biopharmaceutical Sciences, University of Illinois,
Chicago: Towards personalized medicine:
genomic approaches to new target discovery in cancer
Eileen Dolan, PhD, Section of
Hematology/Oncology, Dept of Medicine, University of
Chicago: Genetic variants important in
chemotherapeutic toxicity identified through whole
genomic studies
Eric Blomme, DVM, PhD, Dept of
Cellular, Molecular and Exploratory Toxicology,
Abbott Laboratories: The use of
toxicogenomics in the drug discovery field:
Why, when and how?
|